Retrospective Analysis of Trabectedin Therapy for Soft Tissue Sarcoma

Background/Aim: Trabectedin is a synthetic antineoplastic agent approved for advanced soft tissue sarcoma (STS) in Japan. The aim of this study was to evaluate the efficacy and safety of the Japan-approved dose of trabectedin for advanced STS. Patients and Methods: We retrospectively reviewed 38 pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:In Vivo
Hauptverfasser: KAWAGUCHI, KUNIKI, NAKANO, KENJI, URASAKI, TETSUYA, FUKUDA, NAOKI, TAIRA, SHINICHIRO, ONO, MAKIKO, TOMOMATSU, JUNICHI, NISHIZAWA, MASATOSHI, AE, KEISUKE, MATSUMOTO, SEIICHI, TAKAHASHI, SHUNJI
Format: Artigo
Sprache:Inglês
Veröffentlicht: International Institute of Anticancer Research 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6755008/
https://ncbi.nlm.nih.gov/pubmed/31471412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11644
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge